Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2015

Feb 3, 2015

29745_dirs_2015-02-03_740d69b5-012c-42bf-9d79-af7ecf29e815.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-02-01

Reporting Person: Rice Derica W (EVP-Global Services and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-01 Common Stock M 26581 Acquired 82739 Direct
2015-02-01 Common Stock F 12294 $72 Disposed 70445 Direct
2015-02-02 Common Stock S 10068 $71.84 Disposed 60377 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-01 Restricted Stock Unit $ M 26581 Disposed 2015-02-01 Common Stock (26581.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6958 Indirect
Common Stock 278263 Indirect
Common Stock 1809 Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2014.

F2: This transaction was executed in multiple trades at prices ranging from $71.64 to $71.96. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Reporting person disclaims beneficial ownership of these shares.

F4: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.